#FDA

Nine people across three states have been sickened in an E. coli outbreak linked to Raw Farm's unpasteurized dairy. The company refuses to recall. What does this reveal about food safety systems?

After Trump administration officials publicly promoted leucovorin as a potential autism treatment, new prescriptions for children surged 71% in three months. What happens when government rhetoric moves faster than science?

Experimental peptides flood the wellness market with animal data as evidence. Why millions inject unapproved compounds sold with research disclaimers, and what regulators plan to do about it.

Trump appointee overruled FDA scientists to reject Moderna's mRNA flu vaccine, then reversed course within a week after public backlash. Political interference in vaccine approval raises concerns.

Trump's top vaccine regulator at FDA single-handedly blocked Moderna's mRNA flu vaccine review despite strong internal opposition from career scientists.

Moderna stock fell 8% after FDA declined to review its flu vaccine application, highlighting challenges in expanding beyond COVID-19 vaccines into competitive markets.

FDA refuses to review Moderna's mRNA flu vaccine application, marking a shift in vaccine policy under RFK Jr's leadership

A Harvard professor's startup just got FDA approval for the world's first targeted human age reversal experiment. Silicon Valley has invested hundreds of millions in 'reprogramming' technology.

SK Biopharmaceuticals has secured US FDA Phase 1 clearance for its RPT drug candidate SKL35501. It's the first Korean firm to enter alpha-emitter RPT trials in the US.

KAIST and Neogenlogic have unveiled a world-first KAIST personalized cancer vaccine AI model that predicts B-cell immunity to prevent recurrence. Clinical trials planned for 2027.

The US FDA has approved the first-ever pill form of Novo Nordisk's blockbuster weight-loss drug, Wegovy. Showing comparable results to the injection in trials, the daily pill is set to launch in January 2026.

The FDA has approved a once-daily pill version of Novo Nordisk's blockbuster weight-loss drug Wegovy, offering a new option versus the weekly shot and escalating competition with Eli Lilly.